Related Experiment Videos

[Use of cefotaxime in severe infections in newborn infants]

Pathologie-Biologie
|December 1, 1984
PubMed

Insights

Cefotaxime effectively treats neonatal infections caused by Gram-negative bacteria, achieving an 86% success rate in Enterobacteria cases. However, ampicillin remains crucial for Listeria or Streptococcus D infections.

Area of Science:

  • Neonatal infections
  • Antibiotic efficacy
  • Pharmacology

Related Concept Videos